Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Apr 1;77(4):1404-1427.
doi: 10.1002/hep.32774. Epub 2022 Oct 11.

Geographical similarity and differences in the burden and genetic predisposition of NAFLD

Terry Cheuk-Fung Yip  1   2 , Eduardo Vilar-Gomez  3 , Salvatore Petta  4 , Yusuf Yilmaz  5   6 , Grace Lai-Hung Wong  1   2 , Leon A Adams  7   8 , Victor de Lédinghen  9   10 , Silvia Sookoian  11   12 , Vincent Wai-Sun Wong  1   2
Affiliations
Review

Geographical similarity and differences in the burden and genetic predisposition of NAFLD

Terry Cheuk-Fung Yip et al. Hepatology. .

Abstract

NAFLD has become a major public health problem for more than 2 decades with a growing prevalence in parallel with the epidemic of obesity and type 2 diabetes (T2D). The disease burden of NAFLD differs across geographical regions and ethnicities. Variations in prevalence of metabolic diseases, extent of urban-rural divide, dietary habits, lifestyles, and the prevalence of NAFLD risk and protective alleles can contribute to such differences. The rise in NAFLD has led to a remarkable increase in the number of cases of cirrhosis, hepatocellular carcinoma, hepatic decompensation, and liver-related mortality related to NAFLD. Moreover, NAFLD is associated with multiple extrahepatic manifestations. Most of them are risk factors for the progression of liver fibrosis and thus worsen the prognosis of NAFLD. All these comorbidities and complications affect the quality of life in subjects with NAFLD. Given the huge and growing size of the population with NAFLD, it is expected that patients, healthcare systems, and the economy will suffer from the ongoing burden related to NAFLD. In this review, we examine the disease burden of NAFLD across geographical areas and ethnicities, together with the distribution of some well-known genetic variants for NAFLD. We also describe some special populations including patients with T2D, lean patients, the pediatric population, and patients with concomitant liver diseases. We discuss extrahepatic outcomes, patient-reported outcomes, and economic burden related to NAFLD.

PubMed Disclaimer

References

    1. Powell EE, Wong VW, Rinella M. Non‐alcoholic fatty liver disease. Lancet. 2021;397:2212–2224.
    1. NCD Risk Factor Collaboration (NCD‐RisC). Worldwide trends in body‐mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population‐based measurement studies in 128.9 million children, adolescents, and adults. Lancet. 2017;390:2627–42.
    1. NCD Risk Factor Collaboration (NCD‐RisC). Rising rural body‐mass index is the main driver of the global obesity epidemic in adults. Nature. 2019;569:260–4.
    1. Estes C, Anstee QM, Arias‐Loste MT, Bantel H, Bellentani S, Caballeria J, et al. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016‐2030. J Hepatol. 2018;69:896–904.
    1. Estes C, Chan HLY, Chien RN, Chuang WL, Fung J, Goh GBB, et al. Modelling NAFLD disease burden in four Asian regions‐2019–2030. Aliment Pharmacol Ther. 2020;51:801–11.

MeSH terms